- Home
- TLRY vs BCX Comparison
TLRY vs BCX Comparison
Compare TLRY & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | BCX |
|---|---|---|
| Founded | N/A | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.6M | 987.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | BCX |
|---|---|---|
| Price | $7.47 | $13.12 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $103.33 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 370.6K |
| Earning Date | 01-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.99% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $837,323,000.00 | N/A |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.98 | N/A |
| 52 Week Low | $3.51 | $8.25 |
| 52 Week High | $23.20 | $9.90 |
Technical Indicators
Market Signals| Indicator | TLRY | BCX |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 65.20 |
| Support Level | $7.41 | $12.97 |
| Resistance Level | $8.31 | $13.37 |
| Average True Range (ATR) | 0.42 | 0.32 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 32.03 | 79.80 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About BCX BlackRock Resources of Beneficial Interest
BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.